Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
APDN logo APDN
Upturn stock rating
APDN logo

Applied DNA Sciences Inc (APDN)

Upturn stock rating
$3.84
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/15/2025: APDN (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $1.5

1 Year Target Price $1.5

Analysts Price Target For last 52 week
$1.5 Target price
52w Low $2.13
Current$3.84
52w High $319.95

Analysis of Past Performance

Type Stock
Historic Profit -83.21%
Avg. Invested days 33
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/15/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 7.26M USD
Price to earnings Ratio -
1Y Target Price 1.5
Price to earnings Ratio -
1Y Target Price 1.5
Volume (30-day avg) 1
Beta 0.13
52 Weeks Range 2.13 - 319.95
Updated Date 10/15/2025
52 Weeks Range 2.13 - 319.95
Updated Date 10/15/2025
Dividends yield (FY) -
Basic EPS (TTM) -57.12

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1213.58%

Management Effectiveness

Return on Assets (TTM) -64.06%
Return on Equity (TTM) -137.05%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 901732
Price to Sales(TTM) 1.94
Enterprise Value 901732
Price to Sales(TTM) 1.94
Enterprise Value to Revenue 0.24
Enterprise Value to EBITDA -0.34
Shares Outstanding 1291465
Shares Floating 1291439
Shares Outstanding 1291465
Shares Floating 1291439
Percent Insiders 1.11
Percent Institutions 6.92

ai summary icon Upturn AI SWOT

Applied DNA Sciences Inc

stock logo

Company Overview

overview logo History and Background

Applied DNA Sciences Inc. was founded in 1983. Initially focused on DNA-based security solutions, it has evolved into a company offering DNA-based technologies for supply chain security, anti-counterfeiting, and molecular diagnostics. Significant milestones include developing SigNature DNA and expanding into biotherapeutics.

business area logo Core Business Areas

  • DNA-Based Security Solutions: Provides DNA tagging and tracking solutions for supply chain security, anti-counterfeiting, and brand protection. These solutions help ensure product authenticity and traceability.
  • Molecular Diagnostics: Develops and commercializes DNA-based diagnostic tests for human and animal health, focusing on rapid and accurate detection of pathogens and diseases.
  • Aptamer Production: Develops and produces aptamers for various applications, including diagnostics, therapeutics, and research. Aptamers are single-stranded DNA or RNA molecules that bind to specific target molecules.

leadership logo Leadership and Structure

Dr. James Hayward is the President and CEO. The company has a board of directors overseeing its strategic direction. Organizational structure is based on the key business areas.

Top Products and Market Share

overview logo Key Offerings

  • SigNature DNA: DNA-based security solution for marking and authenticating products. Used in textiles, pharmaceuticals, and other industries. Market share is difficult to quantify precisely, but APDN is a recognized leader in DNA tagging. Competitors include authentication technology companies and label providers like OpSec Security and Avery Dennison.
  • LineaTM DNA: Linear, double-stranded DNA used as a master template for nucleic acid therapeutics and diagnostics. No reliable market share data. Competitors include companies producing plasmid DNA such as Aldevron (Danaher), Thermo Fisher Scientific.

Market Dynamics

industry overview logo Industry Overview

The industries in which Applied DNA Sciences operates are highly competitive and rapidly evolving. Supply chain security is driven by globalization and the need to combat counterfeiting. Molecular diagnostics is growing due to advancements in technology and increasing demand for personalized medicine. The aptamer market is emerging with potential applications in therapeutics and diagnostics.

Positioning

Applied DNA Sciences Inc. is positioned as a leader in DNA-based security solutions and an innovator in molecular diagnostics and biotherapeutics. Its competitive advantages include its patented DNA tagging technology and its expertise in DNA manufacturing.

Total Addressable Market (TAM)

The estimated TAM for DNA-based security solutions, molecular diagnostics, and biotherapeutics is in the billions of dollars. APDN is focused on capturing market share in these segments with its proprietary technologies.

Upturn SWOT Analysis

Strengths

  • Proprietary DNA tagging technology
  • Expertise in DNA manufacturing
  • Established partnerships with key industry players
  • IP portfolio

Weaknesses

  • Limited financial resources
  • Dependence on key customers
  • Relatively small market capitalization
  • History of fluctuating revenue

Opportunities

  • Expanding applications of DNA tagging in new industries
  • Growing demand for molecular diagnostics
  • Strategic partnerships and acquisitions
  • Government contracts related to biosecurity.

Threats

  • Competition from established players
  • Technological advancements by competitors
  • Regulatory changes
  • Economic downturns

Competitors and Market Share

competitor logo Key Competitors

  • SNPS
  • ILMN
  • TMO

Competitive Landscape

Applied DNA Sciences Inc. faces intense competition from larger, more established companies with greater financial resources. Its advantages lie in its proprietary DNA tagging technology and expertise in certain niche markets.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been inconsistent, with periods of rapid expansion followed by contractions.

Future Projections: Analyst estimates for future growth vary widely, reflecting the uncertainty surrounding the company's prospects. Success in molecular diagnostics and biotherapeutics is crucial for future growth.

Recent Initiatives: Recent initiatives include expanding its diagnostic testing capabilities and partnerships for LINEA DNA.

Summary

Applied DNA Sciences Inc. is a small company with a unique DNA tagging technology, but it faces significant financial challenges and intense competition. Its success depends on expanding its diagnostic testing capabilities and achieving profitability. Investors should be aware of the high risk associated with this stock. The company has some novel technologies, but needs to be careful in spending.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings (10-K, 10-Q)
  • Company Website
  • Third-party financial data providers
  • Analyst Reports
  • Press Releases

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual risk tolerance and due diligence. Market data is subject to change.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Applied DNA Sciences Inc

Exchange NASDAQ
Headquaters Stony Brook, NY, United States
IPO Launch date 2003-07-15
President, CEO Chief Legal Off, Executive Director of Business Dev & President of LineaRx, Inc. Mr. Clay Shorrock Esq., J.D.
Sector Healthcare
Industry Diagnostics & Research
Full time employees 46
Full time employees 46

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York.